We harness the power of computational biology and data science to accelerate drug discovery, optimize therapeutic development, and unlock new possibilities in personalized medicine.
At Quantivo.bio, we bridge the gap between biological complexity and computational precision, delivering breakthrough solutions for the life sciences industry.
Leveraging genomics and AI to develop personalized therapeutic approaches tailored to individual patient profiles.
Accelerating the identification and optimization of novel therapeutic compounds through computational modeling and simulation.
Advanced analytics for biomarker discovery and validation, enabling better diagnostic and prognostic capabilities.
Comprehensive biotechnology solutions powered by cutting-edge computational biology and data science.
Comprehensive analysis of genomic datasets using advanced bioinformatics pipelines and machine learning algorithms.
Artificial intelligence solutions for protein folding prediction, molecular design, and therapeutic target identification.
Data-driven approaches to improve clinical trial design, patient stratification, and outcome prediction.
World-class scientists, engineers, and researchers dedicated to advancing biotechnology through computational innovation.
Chief Executive Officer
PhD in Computational Biology from MIT. Former research director at leading pharma companies.
Chief Technology Officer
Expert in AI and machine learning applications in drug discovery and genomics.
Chief Scientific Officer
Leading researcher in precision medicine and biomarker discovery with 15+ years experience.
Ready to transform your biotechnology research? Let's discuss how Quantivo.bio can accelerate your scientific discoveries.
contact@quantivo.bio
+1 (889) 656-2359
San Francisco, CA